Skip to main content

Advertisement

Table 2 Baseline laboratory evaluation

From: The role of enteric hormone GLP-2 in the response of bone markers to a mixed meal in postmenopausal women with type 2 diabetes mellitus

Variable Reference range Groups T2D (n = 23) Group CO (n = 20) p-value
Mean (SD) Mean (SD)
FSH (IU/L) 31 to 134 49.7 (16.5) 78.1 (13.4) < 0.001
LH (IU/L) 15 to 64 24.2 (12.4) 36.2 (11.4) 0.012
Estradiol (pg/mL) <25 15.7 (2.7) 17,9 (6.0) 0.15
Total calcium (mg/dL) 8.6 to 10.2 9.6 (0.6) 9.3 (0.6) 0.129
Phosphorus (mg/dL) 2.7 to 4.5 3.9 (0.5) 3.6 (0.5) 0.164
PTH (pg/mL) 16 to 87 45.3 (18.8) 51.1 (17.0) 0.237
25-OHD (ng/mL) 30 to 100 21.3 (8.5) 20.4 (5.2) 0.685
CTX (ng/mL) 0.142 to 1.351 0.49 (0.25) 0.66 (0.22) 0.04
Osteocalcin (ng/mL) 5 to 25 10.2 (5.4) 14.8 (5.3) 0.008
GLP-2 (ng/mL) 1 to 6415 4.1 (2.0) 3.8 (1.8) 0.61
24-hour urinary calcium (mg/24 h) 100 to 320 174.7 (91.6) 151.9 (63.2) 0.44
  1. T2D, type 2 diabetes; CO, control; SD, standard deviation; p-value, Student’s t-test p-value; FSH, follicle-stimulating hormone; LH, luteinizing hormone; PTH, parathyroid hormone; CTX, C-terminal telopeptide of type I collagen; GLP-2, Glucagon-like peptide 2.